Breaking News, Collaborations & Alliances

SCTbio, Cyto-care Partner to Improve Cell Therapy Capabilities

Aims to address need for efficient collection, cryopreservation, quality control and logistics capabilities of leukapheresis materials.

SCTbio, a full-service contract development and manufacturing organization (CDMO) specializing in cell-based therapy and viral vectors, and Cyto-care.eu, GmbH, a company that specializes in providing advanced solutions for cell therapy and regenerative medicine, entered into a collaboration agreement to improve the quality of cryopreservation for cell therapy development in Europe. The collaboration aims to address the critical need for efficient collection, cryopreservation, quality control ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters